PLTR: Bullish Momentum Meets Valuation Wall — Wait for Better Entry

What happened

A new Seeking Alpha article reiterates a Buy rating, citing Q2 2026 revenue growth of 94% YoY and adjusted EPS growth of 156%, with commercial momentum accelerating and net dollar retention of ~157%. However, the DeepValue master report maintains a Wait rating with an attractive entry at $155 and a trim above $205, arguing that at the current price of $185.7 the stock already prices in uninterrupted conversion from bookings to revenue. The report highlights that company-wide RPO stands at $4.9 billion—only modestly higher than prior quarters—while U.S. commercial remaining deal value and total contract value have surged 124% and 153% YoY, respectively, indicating a widening gap between headline deals and hard backlog. Additionally, concerns include U.S. revenue concentration at 80%, potential procurement friction around the Pentagon’s up-to-$244 million action, and stock-based compensation diluting per-share economics. The market narrative has shifted toward treating Palantir as a sovereign-AI winner, but the next two quarters will be critical to see if bookings convert into deferred revenue and RPO growth sufficient to justify the current multiple.

Implication

The bullish article reinforces that Palantir’s underlying business is firing on all cylinders, with exceptional revenue growth, expanding commercial adoption, and strong net dollar retention. But the valuation remains stretched at 147.6x P/E and 252.5x EV/EBITDA, leaving little room for error if conversion from headline deals to recognized revenue slows. Key monitoring points over the next 90 days include whether RPO grows beyond $4.9B, whether deferred revenue and customer deposits rise in line with commercial deal activity, and whether the Pentagon award finalizes cleanly. If these signals turn positive, the thesis could shift toward a Buy with a higher target; if they disappoint, a correction toward the bear case of $135 is possible. Until then, the risk/reward is not compelling enough to chase the stock above $205, and disciplined investors should hold off or trim into strength.

Thesis delta

The thesis remains unchanged: Palantir's growth is exceptional, but the current price already discounts flawless execution. The article's bullish data points (94% revenue growth, 157% net retention) support the long-term moat, but they do not address the backlog conversion and valuation concerns that underpin the Wait rating. Thus, the Wait stance persists pending further evidence of RPO expansion and international diversification.